论文部分内容阅读
目的:观察恩再适治疗坐骨神经痛的临床疗效及药物的不良反应。方法:将180例患者随机均分为两组,每组90例,治疗组给予恩再适7.2 U+0.9%氯化钠溶液100 ml,1次/d静脉滴注,对照组给予维生素B1、维生素B12肌内注射,口服丙戊酸钠治疗,用视觉模糊评分方法(VAS)评价两组治疗后疼痛的改善程度及药物的不良反应。结果:恩再适治疗组在2周后VAS较治疗前明显下降(P<0.01)有效率达到94.4%,明显优于常规治疗组(75.6%)。结论:恩再适治疗坐骨神经痛效果优于常规治疗组。
Objective: To observe the clinical effect of enoxaparin in the treatment of sciatica and the adverse drug reaction. Methods: One hundred and eighty patients were randomly divided into two groups, 90 cases in each group. The treatment group was enamel 7.2 U + 0.9% sodium chloride solution 100 ml, once / d intravenous infusion, the control group was given vitamin B1, Vitamin B12 intramuscular injection, oral sodium valproate treatment, visual acuity score (VAS) evaluation of two groups after treatment to improve the degree of pain and adverse drug reactions. Results: The VAS in the enoxaparin treatment group decreased significantly (P <0.01) after 2 weeks and the effective rate was 94.4%, which was significantly better than that of the conventional treatment group (75.6%). Conclusion: Enqiu suitable treatment of sciatica is better than the conventional treatment group.